La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Immunohistochemistry »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Immunoglobulin G < Immunohistochemistry < Immunologic Factors  Facettes :

List of bibliographic references indexed by Immunohistochemistry

Number of relevant bibliographic references: 62.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000120 (2017) Candace H. Carriere [Canada] ; Na Hyea Kang [Canada] ; Lennard P. Niles [Canada]Bilateral upregulation of α-synuclein expression in the mouse substantia nigra by intracranial rotenone treatment.
000338 (2016) Yue Shen [Canada] ; Fang Cheng [Finlande] ; Mehul Sharma [Canada] ; Yulia Merkulova [Canada] ; Sheetal A. Raithatha [Canada] ; Leigh G. Parkinson [Canada] ; Hongyan Zhao [Canada] ; Kathryn Westendorf [Canada] ; Lubos Bohunek [Canada] ; Tatjana Bozin [Canada] ; Ivy Hsu [Canada] ; Lisa S. Ang [Canada] ; Sarah J. Williams [Canada] ; R Chris Bleackley [Canada] ; John E. Eriksson [Finlande] ; Michael A. Seidman [Canada] ; Bruce M. Mcmanus [Canada] ; David J. Granville [Canada]Granzyme B Deficiency Protects against Angiotensin II-Induced Cardiac Fibrosis.
000798 (2015) Mattia Volta [Canada] ; Stefano Cataldi [Canada] ; Dayne Beccano-Kelly [Canada] ; Lise Munsie [Canada] ; Igor Tatarnikov [Canada] ; Patrick Chou [Canada] ; Sabrina Bergeron [Canada] ; Emma Mitchell [Canada] ; Roscoe Lim [Canada] ; Jaskaran Khinda [Canada] ; Alejandro Lloret [États-Unis] ; C Frank Bennett [États-Unis] ; Carmela Paradiso [Italie] ; Michele Morari [Italie] ; Matthew J. Farrer [Canada] ; Austen J. Milnerwood [Canada]Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release.
000A13 (2014) Nadine Schweizer [Suède] ; Stéfano Pupe [Suède, Brésil] ; Emma Arvidsson [Suède] ; Karin Nordenankar [Suède] ; Casey J. A. Smith-Anttila [Suède] ; Souha Mahmoudi [Canada] ; Anna Andrén [Suède] ; Sylvie Dumas [France] ; Aparna Rajagopalan [Suède] ; Daniel Lévesque [Canada] ; Richardson N. Leão [Suède, Brésil] ; Sa Wallén-Mackenzie [Suède]Limiting glutamate transmission in a Vglut2-expressing subpopulation of the subthalamic nucleus is sufficient to cause hyperlocomotion
000D59 (2013) Anne L. Wheeler [Canada] ; Cátia M. Teixeira ; Afra H. Wang ; Xuejian Xiong ; Natasa Kovacevic ; Jason P. Lerch ; Anthony R. Mcintosh ; John Parkinson ; Paul W. FranklandIdentification of a functional connectome for long-term fear memory in mice.
001004 (2013) Andrea Gold [Canada] ; Zorbey T. Turkalp [Canada] ; David G. Munoz [Canada]Enteric alpha‐synuclein expression is increased in Parkinson's disease but not Alzheimer's disease
001A70 (2010) Hossein Aleyasin [Canada] ; Maxime W. C. Rousseaux [Canada] ; Paul C. Marcogliese [Canada] ; Sarah J. Hewitt [Canada] ; Isabella Irrcher [Canada] ; Alvin P. Joselin [Canada] ; Mohammad Parsanejad [Canada] ; Raymond H. Kim [Canada] ; Patrizia Rizzu [Pays-Bas] ; Steve M. Callaghan [Canada] ; Ruth S. Slack [Canada] ; Tak W. Mak [Canada] ; David S. Park [Canada, Corée du Sud]DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway
001A77 (2010) Adam L. Boxer [États-Unis] ; Ian R. Mackenzie [Canada] ; Bradley F. Boeve [États-Unis] ; Matthew Baker [États-Unis] ; William W. Seeley [États-Unis] ; Richard Crook [États-Unis] ; Howard Feldman [Canada] ; Ging-Yuek R. Hsiung [Canada] ; Nicola Rutherford [États-Unis] ; Victor Laluz [États-Unis] ; Jennifer Whitwell [États-Unis] ; Dean Foti [Canada] ; Eric Mcdade [États-Unis] ; Jennifer Molano [États-Unis] ; Anna Karydas [États-Unis] ; Aleksandra Wojtas [États-Unis, Pologne] ; Jill Goldman [États-Unis] ; Jacob Mirsky [États-Unis] ; Pheth Sengdy [Canada] ; Stephen Dearmond [États-Unis] ; Bruce L. Miller [États-Unis] ; Rosa Rademakers [États-Unis]Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family
001E00 (2009) Mallika Somayajulu-Ni U [Canada] ; Jagdeep K. Sandhu [Canada] ; Jerome Cohen [Canada] ; Marianna Sikorska [Canada] ; Ts Sridhar [Canada, Inde] ; Anca Matei [Canada] ; Henryk Borowy-Borowski [Canada] ; Siyaram Pandey [Canada]Paraquat induces oxidative stress, neuronal loss in substantia nigra region and Parkinsonism in adult rats: Neuroprotection and amelioration of symptoms by water-soluble formulation of Coenzyme Q10
001E08 (2009) Sohrab P. Shah [Canada] ; Martin Köbel ; Janine Senz ; Ryan D. Morin ; Blaise A. Clarke ; Kimberly C. Wiegand ; Gillian Leung ; Abdalnasser Zayed ; Erika Mehl ; Steve E. Kalloger ; Mark Sun ; Ryan Giuliany ; Erika Yorida ; Steven Jones ; Richard Varhol ; Kenneth D. Swenerton ; Dianne Miller ; Philip B. Clement ; Colleen Crane ; Jason Madore ; Diane Provencher ; Peter Leung ; Anna Defazio ; Jaswinder Khattra ; Gulisa Turashvili ; Yongjun Zhao ; Thomas Zeng ; J N Mark Glover ; Barbara Vanderhyden ; Chengquan Zhao ; Christine A. Parkinson ; Mercedes Jimenez-Linan ; David D L. Bowtell ; Anne-Marie Mes-Masson ; James D. Brenton ; Samuel A. Aparicio ; Niki Boyd ; Martin Hirst ; C Blake Gilks ; Marco Marra ; David G. HuntsmanMutation of FOXL2 in granulosa-cell tumors of the ovary.
002199 (2008) Judith Miklossy [Canada] ; John C. Steele ; Sheng Yu ; Sherman Mccall ; Glenn Sandberg ; Edith G. Mcgeer ; Patrick L. McgeerEnduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC).
002203 (2008) Ivar Mendez [Canada] ; Angel Vi Uela [États-Unis] ; Arnar Astradsson [États-Unis] ; Karim Mukhida [Canada] ; Penelope Hallett [États-Unis] ; Harold Robertson [Canada] ; Travis Tierney [États-Unis] ; Renn Holness [Canada] ; Alain Dagher [Canada] ; John Q. Trojanowski [États-Unis] ; Ole Isacson [États-Unis]Dopamine neurons implanted into people with Parkinson’s disease survive without pathology for 14 years
002229 (2008) A. Scott ; Lian ; C. R. Roberts ; J. L. Cook ; C. J. Handley ; R. Bahr ; T. Samiric ; M. Z. Ilic ; J. Parkinson ; D. A. Hart ; V. Duronio ; K. M. Khan [Canada]Increased versican content is associated with tendinosis pathology in the patellar tendon of athletes with jumper's knee
002317 (2008) Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada]Glial reactions in Parkinson's disease
002440 (2007) Dianbo Qu [Canada] ; Juliet Rashidian ; Matthew P. Mount ; Hossein Aleyasin ; Mohammad Parsanejad ; Arman Lira ; Emdadul Haque ; Yi Zhang ; Steve Callaghan ; Mireille Daigle ; Maxime W C. Rousseaux ; Ruth S. Slack ; Paul R. Albert ; Inez Vincent ; John M. Woulfe ; David S. ParkRole of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease.
002460 (2007) Judith Miklossy [Suisse] ; Hong Qing ; Jian-Ping Guo ; Sheng Yu ; Zbigniew K. Wszolek ; Donald Calne ; Edith G. Mcgeer ; Patrick L. McgeerLrrk2 and chronic inflammation are linked to pallido-ponto-nigral degeneration caused by the N279K tau mutation.
002904 (2006) Evelyn F. Field [Canada] ; Gerlinde A. Metz [Canada] ; Sergio M. Pellis [Canada] ; Ian Q. Whishaw [Canada]Sexually dimorphic postural adjustments during vertical behaviour are altered in a unilateral 6-OHDA rat model of Parkinson's disease
002905 (2006) J. Miklossy [Canada] ; D. D. Doudet [Canada] ; C. Schwab [Canada] ; S. Yu [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada]Role of ICAM-1 in persisting inflammation in parkinson disease and MPTP monkeys
002915 (2006) Rohita Sharma [Canada] ; Catherine R. Mcmillan [Canada] ; Catherine C. Tenn [Canada] ; Lennard P. Niles [Canada]Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease
002919 (2006) Judith Miklossy [Canada] ; Tetsuaki Arai [Japon] ; Jian-Ping Guo [Canada] ; Andis Klegeris [Canada] ; SHENG YU [Canada] ; Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada]LRRK2 expression in normal and pathologic human brain and in human cell lines
002954 (2005) Veronica Hirsch-Reinshagen [Canada] ; Luis F. Maia ; Braydon L. Burgess ; Jean-Francois Blain ; Kathryn E. Naus ; Sean A. Mcisaac ; Pamela F. Parkinson ; Jennifer Y. Chan ; Gavin H. Tansley ; Michael R. Hayden ; Judes Poirier ; William Van Nostrand ; Cheryl L. WellingtonThe absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Immunohistochemistry" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Immunohistochemistry" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Immunohistochemistry
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022